Business

Innovotech Appoints Dr. Craig Milne as Chief Executive Officer

(TheNewswire) Edmonton, Alberta - TheNewswire - 17 July 2023 - Innovotech Inc. ...

articleInnovotech Inc.July 17, 20235/company/innovotech-inc/news/innovotech-appoints-dr-craig-milne-as-chief-executive-officer
Innovotech Appoints Dr. Craig Milne as Chief Executive Officer

About this update from Innovotech Inc.

[{"type":"text","content":"Innovotech Appoints Dr. Craig Milne as Chief Executive Officer\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Edmonton, Alberta -\n \n \n TheNewswire -\n \n \n 17 July 2023 -\n \n \n Innovotech Inc.\n \n \n (TSX-V:IOT)\n \n \n , a leading Canadian biotechnology\ncompany, is pleased to announce the appointment of Dr. Craig Milne as\nChief Executive Officer (CEO) effective 1 August 2023.\n \n \n Dr. Milne first joined IOT as a Board member in July 2019 and\nhas served on the Executive Committee, Audit Committee and as Chief\nBusiness Development Officer. \"Dr. Milne brings to IOT\nenthusiasm, energy, vision and more than a decade of leadership\nexperience in rapidly growing technology companies\" said Dr.\nJames Timourian, present CEO and Board Chair. Craig has a PhD in\nImmunology from the University of Toronto and an MBA in Finance from\nthe University of Alberta.\n \n \n \n \n “I’m excited about the opportunity we have in front\nof us.  Innovotech is recognized by leading medical device companies\nas their trusted partner in microbiology products and services.  That\nis a strong base from where we can continue to add value to our\nbusiness and the industry.” said Dr. Milne.\n \n \n \n \n In his previous role as CEO of Copperstone\nTechnologies, an Edmonton-based robotics company, he led the\nacquisition of several global mining companies as key clients.  He\nhas worked with companies across a number of industry verticals,\ndeveloping and executing effective strategies for sales, partnership\ndevelopment and finance.  Dr. Milne will be granted 500,000 incentive\nstock options vesting over a 4-year period at today’s closing price\nof $0.10 and expiring in 5 years.\n \n \n \n \n Dr. Timourian will resign from the CEO position at the\nend of July and continue supporting the company in his capacity as\nDirector and Board Chair.\n \n \n \n \n About Innovotech Inc:\n \n \n \n \n Innovotech is a Canadian biotechnology company owning\nproprietary intellectual property, conducting contract research, and\nowning and providing proprietary devices for testing in multiple\napplications in microbiology and can be found online at\n \n \n www.innovotech.ca\n \n \n .\n \n \n \n \n Alan Savage\n \n \n \n \n Director & CFO Innovotech Inc. 604...

More updates from Innovotech Inc.